首页> 外国专利> Unit dose form, including a membrane matrix, consisting of a water-soluble polycyclic matrix and 10 to 200 UG estradiol or hydrate or an ester, less than 300 mm thick, useful under physical conditions due to insufficient endocrine Trogenos.

Unit dose form, including a membrane matrix, consisting of a water-soluble polycyclic matrix and 10 to 200 UG estradiol or hydrate or an ester, less than 300 mm thick, useful under physical conditions due to insufficient endocrine Trogenos.

机译:单位剂量形式,包括膜基质,由水溶性多环基质和10至200 UG的雌二醇或水合物或酯组成,厚度小于300毫米,由于内分泌Trogenos不足而在物理条件下有用。

摘要

Unit dosage form comprising a Graft Copolymer Peg and PVA Polymer Matrix Soluble in waterWith a thickness less than 300 micrometers and estradiol as the active principle to prevent the physical conditions generated by insufficient endogenous estrogen levels.
机译:单位剂量形式,包括可溶于水且厚度小于300微米的接枝共聚物聚乙二醇和PVA聚合物基质,并且以雌二醇为有效成分,可防止内源性雌激素水平不足而产生的身体状况。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号